Administration of cardiac mesenchymal cells modulates innate immunity in the acute phase of myocardial infarction in mice

Abstract Although cardiac mesenchymal cell (CMC) therapy mitigates post-infarct cardiac dysfunction, the underlying mechanisms remain unidentified. It is acknowledged that donor cells are neither appreciably retained nor meaningfully contribute to tissue regeneration—suggesting a paracrine-mediated...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi Kang, Marjan Nasr, Yiru Guo, Shizuka Uchida, Tyler Weirick, Hong Li, Jae Kim, Joseph B. Moore, Senthilkumar Muthusamy, Roberto Bolli, Marcin Wysoczynski
Format: article
Language:EN
Published: Nature Portfolio 2020
Subjects:
R
Q
Online Access:https://doaj.org/article/e60037ebf1604f059252e71ae039ca99
Tags: Add Tag
No Tags, Be the first to tag this record!